Review highlights advances in polymeric nanomedicine, pinpointing targeted delivery and challenges in clinical translation.
Polymeric nanomedicine has emerged as a versatile and transformative platform for the delivery of therapeutic agents, offering controlled release, enhanced stability, and targeted delivery across a broad spectrum of medical applications. This review comprehensively discusses the design, functionalization, and therapeutic potential of polymeric nanoparticles, with an emphasis on both natural and synthetic polymers and diverse nanocarrier systems, including nanospheres, nanocapsules, micelles, dendrimers, polymersomes, and nanogels. Advances in surface modification, stimuli-responsive carriers, and multifunctional platforms have enabled precise targeting, improved pharmacokinetics, and reduced off-target toxicity. Key therapeutic applications are explored, spanning cancer therapy, gene therapy, infectious diseases, neurological disorders, and regenerative medicine. The review also addresses challenges in clinical translation, including regulatory hurdles, scalable manufacturing, safety and toxicity considerations, and the design of personalized treatment strategies. Future perspectives highlight the integration of personalized and precision medicine, smart stimuli-responsive polymers, AI/machine learning-driven design optimization, nano-immunotherapy, and hybrid polymeric systems, underscoring their potential to revolutionize global healthcare. By synthesizing current knowledge and outlining translational strategies, this review provides a roadmap for advancing polymeric nanomedicine from bench to bedside, ultimately paving the way for safer, more effective, and patient-specific therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: